Angela Mastronuzzi: Proud of my team at Ospedale Pediatrico Bambino Gesù for this paper published with MDPI.
Angela Mastronuzzi,
” ‘Recent Advancements on the Use of Exosomes as Drug Carriers for the Treatment of Glioblastoma’
Proud of my team at Ospedale Pediatrico Bambino Gesù for this paper published with MDPI.
Glioblastoma (GBM) is the most common and aggressive brain cancer.
Considering the low survival rate among patients affected by GBM, with currently approved treatments, new therapeutic approaches are urgently needed. In the last decade, exosomes have emerged as a promising carrier for drug delivery due to their low immunogenicity and strong biocompatibility. Several studies have demonstrated that exosomes can be used as vehicles for drugs and nucleic acids or be engineered for anti-tumor treatment.”
For the article click here.
Source: Angela Mastronuzzi/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023